New alternatives for control of severe cardiac surgical bleeding-Reference-Cited by-同舟云学术

New alternatives for control of severe cardiac surgical bleeding

Published:2004-01 Issue: Volume:41 Page:174
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Gill Ravi,Herbertson Mike,Diprose Paul

Publisher

Elsevier BV

Subject

Hematology

Reference3 articles.

1. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery;Al Douri;Blood Coagul Fibrinolysis,2000

2. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy;Hedner;Lancet,1988

3. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII;Hendriks;Anesth Analg,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review;The Annals of Thoracic Surgery;2007-02

2. Confirmed Graft Flow Following Use of Recombinant Factor VIIa in Coronary Artery Bypass Grafting: A Case Report and Literature Review;Journal of Cardiac Surgery;2006-09

3. Small-Dose Recombinant Activated Factor VII (NovoSeven??) in Cardiac Surgery;Anesthesia & Analgesia;2006-05

4. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study;British Journal of Anaesthesia;2005-11

5. Determinants of futility of administration of recombinant factor VIIa in trauma;J TRAUMA;2005